Tempus AI Celebrates 10 Years, Impresses Investors with 56% Gains

Tempus AI, a healthcare technology company, is celebrating a major milestone this month – its 10-year anniversary. Founded in August 2015, the company has been making waves in the industry, particularly over the past year since its initial public offering (IPO) in June 2024.

After a rocky start with a 29% plunge in its first week of trading, Tempus AI's stock has since rebounded impressively. As of August 7, 2025, investors who bought the stock at its IPO have seen their investments grow by 56%. Those who purchased the stock exactly one year ago, on August 5, 2024, have enjoyed a 51% increase in the value of their holdings.

The company's success can be attributed to its innovative use of artificial intelligence (AI) to improve patient care and assist researchers in discovering new pharmaceuticals. While Tempus AI is currently unprofitable, its price-to-sales ratio of around 10 suggests the stock may be reasonably valued, given its substantial market opportunity.

Despite the strong performance, the Motley Fool's Stock Advisor team has not included Tempus AI among their top 10 stock picks for the coming years. Nonetheless, the company's continued growth and development of cutting-edge AI solutions have captured the attention of investors and industry observers alike.